APGE · Apogee Therapeutics, Inc.
$134.97
+0.01 (+0.00%)
At close · Aug 28
Going-concern doubt
— cleared Aug 10, 2026
The latest filing states the doubt was alleviated.
“The Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that the accompanying consolidated financial statements are issued. ... Based on the Company's current operating plan, it estimates that its existing cash and cash equivalents of $105.6 million, marketable securities of $866.4 million and long-term marketable securities of $321.9 million as of June 30, 2026, will be sufficient to enable the Company to fund its operating expenses and capital requirements through at least the next 12 months from the issuance of these consolidated financial statements.”View the 10-Q filed Aug 10, 2026
Market Cap
$10.21B
Shares
75.69M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding APGE
283 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF | XBI | 1,203,674 | $159,763,650 | 1.49% | Long | 2026-06-30 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 1,840,364 | $154,903,438 | 0.01% | Long | 2026-03-31 | |
| iShares Russell 2000 ETF | IWM | 1,157,561 | $153,643,072 | 0.19% | Long | 2026-06-30 | |
| Fidelity Growth Company Fund | — | 1,838,574 | $151,020,468 | 0.15% | Long | 2026-05-31 | |
| VANGUARD HEALTH CARE FUND | — | 1,490,737 | $123,567,190 | 0.34% | Long | 2026-04-30 | |
| T. Rowe Price Capital Appreciation Equity ETF | TCAF | 653,461 | $86,733,879 | 1.17% | Long | 2026-06-30 | |
| First Trust Merger Arbitrage Fund | — | 535,455 | $71,070,942 | 4.35% | Long | 2026-06-30 | |
| iShares Russell 2000 Growth ETF | IWO | 416,315 | $55,257,490 | 0.36% | Long | 2026-06-30 | |
| iShares Biotechnology ETF | IBB | 403,675 | $53,579,783 | 0.59% | Long | 2026-06-30 | |
| Fidelity Blue Chip Growth Fund | — | 621,363 | $51,504,779 | 0.05% | Long | 2026-04-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 598,603 | $50,384,415 | 0.06% | Long | 2026-03-31 | |
| Eventide Healthcare & Life Sciences Fund | — | 557,423 | $46,918,294 | 2.96% | Long | 2026-03-31 | |
| Fidelity Growth Company K6 Fund | FGKFX | 544,057 | $44,688,842 | 0.16% | Long | 2026-05-31 | |
| VANGUARD EXPLORER FUND | — | 530,576 | $43,979,445 | 0.20% | Long | 2026-04-30 | |
| Fidelity Series Growth Company Fund | FCGSX | 530,626 | $43,585,620 | 0.18% | Long | 2026-05-31 | |
| Bridge Builder Small/Mid Cap Growth Fund | BBGSX | 298,073 | $39,563,229 | 0.35% | Long | 2026-06-30 | |
| Fidelity Advisor Biotechnology Fund | — | 452,639 | $37,519,247 | 1.97% | Long | 2026-04-30 | |
| Fidelity Small Cap Index Fund | FSSNX | 439,935 | $36,466,212 | 0.11% | Long | 2026-04-30 | |
| Select Biotechnology Portfolio | FBIOX | 398,657 | $32,745,686 | 0.62% | Long | 2026-05-31 | |
| JPMorgan Small Cap Growth Fund | — | 351,529 | $29,588,196 | 1.36% | Long | 2026-03-31 | |
| Driehaus Small Cap Growth Fund | — | 219,702 | $29,161,046 | 1.81% | Long | 2026-06-30 | |
| Janus Henderson Global Life Sciences Fund | — | 207,385 | $27,526,211 | 0.47% | Long | 2026-06-30 | |
| Fidelity Contrafund | — | 195,108 | $25,896,685 | 0.01% | Long | 2026-06-30 | |
| Fidelity Small Cap Growth Fund | — | 299,965 | $24,864,099 | 0.30% | Long | 2026-04-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 277,564 | $22,799,107 | 0.05% | Long | 2026-05-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 263,702 | $21,660,482 | 0.37% | Long | 2026-05-29 | |
| Schwab U.S. Small-Cap ETF | SCHA | 258,020 | $21,193,763 | 0.09% | Long | 2026-05-31 | |
| PGIM Jennison Health Sciences Fund | — | 240,387 | $19,745,388 | 1.42% | Long | 2026-05-29 | |
| Putnam Small Cap Growth Fund | — | 147,256 | $19,545,289 | 0.58% | Long | 2026-06-30 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 228,487 | $18,767,922 | 0.11% | Long | 2026-05-31 | |
| Loomis Sayles Small Cap Growth Fund | — | 203,012 | $17,087,520 | 0.89% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 126,098 | $16,736,988 | 0.14% | Long | 2026-06-30 | |
| JNL/T. Rowe Price Capital Appreciation Equity Fund | — | 93,411 | $12,398,442 | 1.18% | Long | 2026-06-30 | |
| AB Small Cap Growth Portfolio | — | 91,728 | $12,175,057 | 0.39% | Long | 2026-06-30 | |
| Federated Hermes Kaufmann Fund | — | 143,485 | $11,893,472 | 0.26% | Long | 2026-04-30 | |
| JNL Multi-Manager Small Cap Growth Fund | — | 87,358 | $11,595,027 | 0.46% | Long | 2026-06-30 | |
| First Trust Multi-Strategy Fund | — | 86,537 | $11,486,056 | 0.85% | Long | 2026-06-30 | |
| Master Small Cap Index Series | — | 83,147 | $11,036,101 | 0.18% | Long | 2026-06-30 | |
| Fidelity Small Cap Growth K6 Fund | FOCSX | 126,676 | $10,500,174 | 0.24% | Long | 2026-04-30 | |
| Fidelity Blue Chip Growth K6 Fund | FBCGX | 124,951 | $10,357,188 | 0.05% | Long | 2026-04-30 | |
| VIP Contrafund Portfolio | — | 75,600 | $10,034,388 | 0.03% | Long | 2026-06-30 | |
| iShares Core S&P Total U.S. Stock Market ETF | ITOT | 75,132 | $9,972,270 | 0.01% | Long | 2026-06-30 | |
| JPMorgan Small Cap Blend Fund | — | 113,530 | $9,555,820 | 0.67% | Long | 2026-03-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 114,611 | $9,414,148 | 0.05% | Long | 2026-05-31 | |
| Capital Appreciation Value Fund | JCAVX | 114,300 | $9,388,602 | 0.66% | Long | 2026-05-31 | |
| Fidelity Series Blue Chip Growth Fund | FSBDX | 113,014 | $9,367,730 | 0.05% | Long | 2026-04-30 | |
| AB DISCOVERY GROWTH FUND, INC. | — | 69,058 | $9,166,068 | 0.32% | Long | 2026-06-30 | |
| Fidelity Advisor New Insights Fund | — | 66,100 | $8,773,453 | 0.03% | Long | 2026-06-30 | |
| Fidelity Total Market Index Fund | FSKAX | 100,880 | $8,286,283 | 0.01% | Long | 2026-05-31 | |
| Schwab Small-Cap Index Fund | SWSSX | 97,424 | $8,075,475 | 0.11% | Long | 2026-04-30 |
Showing 1–50 of 283 positions
Key facts
CIK
1974640
CUSIP
03770N101
13F (30d)
260 filings
260 filers
Visit website
Investor relations